Author

Laura Olson

Laura Olson

Laura covers the nation's capital as a senior reporter for States Newsroom, a network of nonprofit outlets that includes New Jersey Monitor. Her areas of coverage include politics and policy, lobbying, elections, and campaign finance.

FDA panel recommends OK for Pfizer’s vaccine for kids 5 to 11

By: - October 26, 2021

WASHINGTON — A federal vaccine advisory panel on Tuesday recommended authorizing Pfizer’s COVID-19 vaccine for children ages 5 to 11, a decision that means as soon as next week everyone in the U.S. over age 5 is expected to be eligible for a shot. The vote by the Food & Drug Administration panel, with 17 […]

COVID-19 vaccines for kids ages 5 to 11 could be ready as soon as next week

By: - October 26, 2021

WASHINGTON — The next wave of the massive COVID-19 vaccination campaign could begin as soon as next week, after federal regulators decide if elementary school students across the U.S. should begin rolling up their tiny sleeves. That multistep approval process kicks off Tuesday, when the Food & Drug Administration’s panel of vaccine experts will vote on […]

Feds OK ‘mix-and-match’ approach for COVID-19 booster shots

By: - October 20, 2021

WASHINGTON — The U.S. Food and Drug Administration has given a green light to Americans who want to receive a booster dose of a COVID-19 vaccine manufactured by a different company than the one that produced the initial shot they received. The announcement Wednesday on allowing “mix-and-match” shots from different manufacturers will give more flexibility to […]

Kids age 5 to 11 next in line for COVID-19 vaccines as White House rolls out plans

By: - October 20, 2021

WASHINGTON — Smaller needles. Redesigned shipments to ease the storage needs in pediatricians’ offices. And enough vials of the COVID-19 vaccine to inoculate the 28 million U.S. children between ages 5 and 11. Those are among the plans announced by the White House on Wednesday as federal and state officials prepare for a regulatory decision […]

Booster shot of Johnson & Johnson COVID-19 vaccine recommended by FDA panel

By: - October 15, 2021

WASHINGTON — A federal vaccine advisory panel on Friday endorsed a second dose of Johnson & Johnson’s one-shot COVID-19 vaccine, meaning millions more Americans are expected to soon join the line for booster shots. Anyone who received a J&J shot at least two months ago will be eligible for an additional dose, under the committee’s […]

FDA panel recommends booster shot of Moderna’s COVID-19 vaccine

By: - October 15, 2021

WASHINGTON — Millions of Americans who received Moderna’s two-shot COVID-19 vaccine are expected to be eligible soon for booster shots, after a federal advisory panel on Thursday recommended a third dose for older and higher-risk adults as well as certain workers. The unanimous recommendation from the Food and Drug Administration vaccine panel came a few […]

Misinformation abounds as U.S. House panel questions Arizona’s presidential election ‘audit’

By: - October 7, 2021

WASHINGTON — It didn’t take long for Thursday’s congressional hearing about a controversial ballot review in Arizona to demonstrate the persistent misinformation about the validity of last year’s presidential election. Rep. Jamie Raskin, a Maryland Democrat, asked his colleague, Arizona Republican Andy Biggs, if he accepts the findings of the GOP-led review of ballots in Maricopa […]

Why there’s such an impasse in Congress: Some questions and answers

By: and - October 4, 2021

WASHINGTON — Congress may have kept the federal government operating with an 11th-hour flurry of votes on Thursday, but several key pieces of the Democratic agenda remain in limbo. Here are some questions and answers on where negotiations stand with two massive Democratic-drafted bills — and the status of other looming challenges for federal lawmakers:  President […]

Congress passes bill to prevent government shutdown, send out $28.6B in disaster aid

By: - September 30, 2021

WASHINGTON — Congress made a last-minute dash to avert a government shutdown on Thursday, with the U.S. Senate and House approving a short-term spending bill just hours ahead of a midnight deadline. Every Democratic and independent senator and 15 Republicans supported the bill in the 65-35 vote. The GOP senators in the “aye” tally included […]

‘Their tank is empty’: Local public health officials combat staff burnout, low pay, harassment

By: - September 30, 2021

WASHINGTON — Eighteen months into the COVID-19 pandemic, state and local public health departments that were already struggling with too few workers and too little money have been pushed to the brink — and for some, beyond the brink.  “My staff is burnt out, overworked and underpaid,” Dr. Mysheika Roberts, health commissioner with the Columbus Public Health […]

Senate GOP torpedoes U.S. government funding bill, raising odds of federal fiscal crises

By: - September 28, 2021

WASHINGTON — U.S. Senate Republicans blocked an attempt by Democrats on Monday evening to begin debate on a broad bill that would avert multiple looming fiscal crises for the federal government. The measure to briefly keep the government operating past the end of the fiscal year on Thursday, as well as to increase the borrowing limit […]

Who will get a booster shot? A Q-and-A about what the feds are saying

By: - September 24, 2021

WASHINGTON — Booster shots soon will begin rolling out to some Americans who received the two-shot vaccine made by Pfizer—after a contentious and confusing federal approval process that isn’t over yet. Determining who exactly should be rolling up their sleeves for an additional dose was tricky. The Biden administration had leapfrogged federal regulatory panels in […]